4.0 Mandatory Patient Assessment and Contraindications
Rigorous patient assessment by a qualified physician is the single most critical step in preventing adverse events and is a non-negotiable prerequisite to the administration of IV Vitamin Therapy. This evaluation ensures that the treatment is appropriate for the patient’s specific health condition and identifies any contraindications that pose a significant risk.
This therapy is contraindicated or requires extreme caution in the following patient populations due to specific risk factors:
| Patient Group / Condition | Primary Risk Factor |
| Chronic Kidney Disease | Impaired clearance of components, potentially leading to toxic accumulation and increased load on the kidneys. |
| Chronic Liver Disease | Reduced ability to metabolize and clear components, creating an additional metabolic burden on the liver. |
| Heart Disease / Blood Pressure Issues | Risk of sudden changes in blood pressure (hypotension or hypertension) due to rapid fluid and mineral infusion. |
| Pregnancy and Breastfeeding | The effects of high-dose IV vitamins on fetal development or on a nursing infant are not well-established. |
| Regular Medication Use | Potential for interactions between the infused components and the patient’s existing medications. |
Under no circumstances shall IV Vitamin Therapy be administered without explicit physician evaluation and approval. This is especially critical for any individual with a chronic health condition or those taking regular medication. Ignoring these contraindications can lead directly to the serious adverse events detailed in the following section.